News
DOCS
24.32
+1.29%
0.31
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Doximity, Inc. Class Period: February 9, 2022 – April 1, 2024 Lead Plaintiff Deadline: June 17, 2024 If you are a shareholder who suffered a loss, click here to participate. The complaint alleges that Defendants made misleading statements about the Company's business prospects.
PR Newswire · 14h ago
Doximity, Inc. (DOCS) Investors: June 17, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Doximity, Inc. Investors who purchased or acquired Dox proximity common stock between February 9, 2022, and April 1, 2024 may move the court to serve as lead plaintiff for the class. The Company operates a digital platform that provides connections between, and patient scheduling tools for medical professionals.
PR Newswire · 1d ago
Doximity, Inc. (DOCS) Investors: June 17, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Doximity, Inc. On behalf of investors who purchased or acquired common stock between February 9, 2022 and April 1, 2024. The class action was filed in the U.S. District Court.
Barchart · 1d ago
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Doximity, Inc. (DOCS)
Glancy Prongay & Murray LLP reminds investors of the upcoming June 17, 2024 deadline to file a lead plaintiff motion in the class action lawsuit against Doximity, Inc. Investors who purchased or otherwise acquired Dox proximity common stock between February 9, 2022, and April 1, 2024, may be eligible to join the lawsuit. The complaint alleges that the company made false and misleading statements.
Barchart · 2d ago
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Doximity, Inc. (DOCS)
Law Offices of Howard G. Smith reminds investors of the upcoming June 17, 2024 deadline to file a lead plaintiff motion in the case of Doximity, Inc. Investors who purchased the Company’s common stock between February 9, 2022 and April 1, 2024 are encouraged to contact the firm.
Barchart · 3d ago
Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for Northern District of California against Doximity, Inc.
Upcoming Lead Plaintiff Deadline is June 17, 2024. A securities class action lawsuit has been filed in the U.S. District Court for the Northern District of California. Doximity, Inc. Common stock is being sued on behalf of all persons and entities who purchased securities of the company.
Barchart · 3d ago
Doximity’s Strong Market Position Amidst Economic Headwinds: A Balanced Hold Recommendation
TipRanks · 3d ago
Weekly Report: what happened at DOCS last week (0422-0426)?
Weekly Report · 3d ago
Doximity: Significant Upside Remains, But Not Until The Growth Story Returns
Doximity is a cloud platform for US medical professionals that has severely underperformed the S&P 500 and Nasdaq 100. The company's revenue and earnings are growing, but the company's slowing revenue growth and customer churn remain concerns. Doximity's robust product pipeline and focus on AI-led innovation are positive factors for future growth. However, declining customers with $100K+ in subscription revenue and weakening Net Retention Rate, along with macroeconomic headwinds are challenges for the company.
Seeking Alpha · 4d ago
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS
The Rosen Law Firm announces the filing of a class action lawsuit on behalf of purchasers of common stock of Doximity, Inc. Between February 9, 2022 and April 1, 2024. A class action has already been filed. You may be entitled to compensation without payment of out of pocket fees.
PR Newswire · 5d ago
DOXIMITY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCS
Investors have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Doximity, Inc. This action is pending in the United States District Court for the Northern District California. KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr.
Barchart · 6d ago
Zacks Industry Outlook Highlights Elevance Health Medpace and Doximity
NASDAQ · 6d ago
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Doximity, Inc. (DOCS) Investors
A class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Doximity, Inc. Common stock between February 9, 2022, and April 1, 2024. Investors have until June 17, 2024 to file a lead plaintiff motion. Glancy Prongay & Murray LLP is a leading national shareholder rights law firm.
Barchart · 6d ago
Press Release: Doximity to Release Fiscal 2024 Fourth Quarter and Full Year Results on May 16, 2024
Doximity to Release Fiscal 2024 Fourth Quarter and Full Year Results on May 16, 2024. Doximity is the leading digital platform for U.S. Medical professionals. The company will report financial results for its fiscal fourth quarter and full year ended March 31, 2024 after market close. A conference call and webcast will be held to discuss the financial results.
Dow Jones · 04/25 20:52
3 Medical Services Industry Stocks to Buy as Nursing Market Booms
NASDAQ · 04/25 15:07
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Doximity, Inc. (DOCS) Investors
Law Offices of Howard G. Smith announces a class action lawsuit has been filed on behalf of investors who purchased Doximity, Inc. Common stock between February 9, 2022, and April 1, 2024. Investors have until June 17, 2024 to file a lead plaintiff motion. The class action alleges that Defendants made materially false and/or misleading statements.
Barchart · 04/25 14:45
Doximity upgraded to neutral at J.P. Morgan but moves to sidelines
Healthcare Doximity upgraded to neutral at J.P. Morgan but moves to sidelines. The firm has a $25 price target for the stock. The company is projecting 16% year over year revenue growth in fiscal 2024. J.p. Morgan has upgraded the company to neutral from underweight.
Seeking Alpha · 04/25 13:45
Doximity Price Target Announced at $25.00/Share by JP Morgan
Dow Jones · 04/25 12:57
Doximity Raised to Neutral From Underweight by JP Morgan
Dow Jones · 04/25 12:57
JP Morgan Upgrades Doximity to Neutral, Announces $25 Price Target
Benzinga · 04/25 12:48
More
Webull provides a variety of real-time DOCS stock news. You can receive the latest news about Doximity Inc through multiple platforms. This information may help you make smarter investment decisions.
About DOCS
Doximity, Inc. provides a digital platform for United States (U.S) medical professionals. The Company's cloud-based platform provides tools to its members, which help them to collaborate with colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with medical news and research, and manage careers. The Company supports physicians in practice of medicine with mobile and clinical workflow tools, such as voice and video telehealth, secure messaging and digital faxing. The Company's platform offers marketing, hiring, and telehealth solutions. Its marketing solutions enable pharmaceutical and health system customers to get content, services, and peer connections to medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms. Its telehealth solutions consist of software tools that include voice and video dialers, designed to connect patients with care providers.